Consumers for Paper Options Urges FDA to Rescind Switch to Electronic Drug Labeling

"The U.S. is not ready for an all-electronic drug labeling mandate," said John Runyan, executive director of Consumers for Paper Options. "According to the FDA's own survey, many pharmacists expressed concern over e-labeling due to Internet connectivity issues or browsing restrictions at the pharmacy level. Paper format is still the most effective and reliable means of communicating potentially life-saving information about drug interactions, dosing and other safety restrictions."